The legacy of Viagra, and its developer copyright, presents a complex case study for investors. At first a blockbuster drug, producing billions in sales , its intellectual property lapse created a wave of lower-priced alternatives , significantly diminishing its dominance. While certain businesses may attempt to capitalize on related treatments , t